These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10182707)

  • 21. [Vaccination of children in 1999].
    Levy J
    Rev Med Brux; 1999 Sep; 20(4):A317-20. PubMed ID: 10523915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MMR immunisation: what advice should we give to parents?
    Rose V
    Prof Care Mother Child; 1998; 8(3):58-9. PubMed ID: 9814351
    [No Abstract]   [Full Text] [Related]  

  • 23. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination vaccines.
    Chokephaibulkit K
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S694-9. PubMed ID: 12403249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
    Goh P; Lim FS; Han HH; Willems P
    Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHIP shots: association between the State Children's Health Insurance Programs and immunization rates.
    Joyce T; Racine A
    Pediatrics; 2005 May; 115(5):e526-34. PubMed ID: 15867017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination vaccine use and vaccination quality in a managed care population.
    Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S
    Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vaccination and immunization in healthcare workers, towards specific infections: measles, varicella, rubella and mumps. The experience in a hospital in Lombardy].
    Cologni L; Belotti L; Bacis M; Bigoni F; Grigis A; Passerini C; Locati F; Mosconi G
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):413-4. PubMed ID: 18409751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.
    Halperin SA; McGrath P; Smith B; Houston T
    J Pediatr; 2000 Jun; 136(6):789-94. PubMed ID: 10839878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine information statements. Revolutionary but neglected educational advances in healthcare in the United States.
    Edlich RF; Martin ML; Foley ML; Gebhart JH; Winters KL; Britt LD; Long WB; Gubler KD
    J Long Term Eff Med Implants; 2005; 15(1):91-114. PubMed ID: 15715520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Educating teens about vaccines.
    Hernandez G; Nestor C
    J Pediatr Health Care; 2006; 20(5):342-9. PubMed ID: 16962442
    [No Abstract]   [Full Text] [Related]  

  • 33. MMR vaccination and autism 1998. Those giving MMR vaccine had no input into editorial.
    Kiln MR
    BMJ; 1998 Jun; 316(7147):1824. PubMed ID: 9652942
    [No Abstract]   [Full Text] [Related]  

  • 34. MMR vaccination and autism 1998. Medical practitioners need to give more than reassurance.
    Selway
    BMJ; 1998 Jun; 316(7147):1824. PubMed ID: 9652941
    [No Abstract]   [Full Text] [Related]  

  • 35. The MMR vaccine debate.
    Community Nurse; 1998 Oct; 4(9):12-3. PubMed ID: 10326363
    [No Abstract]   [Full Text] [Related]  

  • 36. Measles, mumps, and rubella: prevention.
    Booy R; Sengupta N; Bedford H; Elliman D
    Clin Evid; 2006 Jun; (15):448-68. PubMed ID: 16973018
    [No Abstract]   [Full Text] [Related]  

  • 37. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
    Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
    Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interim polio vaccine information materials. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Notice.
    Fed Regist; 1999 Feb; 64(35):9040-2. PubMed ID: 10557593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.